ArticleBlood advances2022
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation.
H Joachim DeegPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it